Skip Navigation

Cardiovascular Research 2006 71(2):247-258; doi:10.1016/j.cardiores.2006.05.001
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Paravicini, T. M.
Right arrow Articles by Touyz, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paravicini, T. M.
Right arrow Articles by Touyz, R. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2006, European Society of Cardiology

Redox signaling in hypertension

Tamara M. Paravicini and Rhian M. Touyz*

Kidney Research Centre, Ottawa Health Research Institute, University of Ottawa, 451 Smyth Road, Ottawa, K1H 8M5, Ontario, Canada

* Corresponding author. Tel.: +1 613 562 5800x8241; fax: +1 613 562 5487. Email address: rtouyz{at}uottawa.ca

Diseases such as hypertension, atherosclerosis and diabetes are associated with vascular functional and structural changes including endothelial dysfunction, altered contractility and vascular remodeling. Cellular events underlying these processes involve changes in vascular smooth muscle cell (VSMC) growth, apoptosis/anoikis, cell migration, inflammation, and fibrosis. Many stimuli influence cellular changes, including mechanical forces, such as shear stress, and vasoactive agents, of which angiotensin II (Ang II) appears to be amongst the most important. Ang II mediates many of its pleiotropic vascular effects through NAD(P)H oxidase-derived reactive oxygen species (ROS). Mechanical forces, comprising both unidirectional laminar and oscillatory shear, are increasingly being recognized as important inducers of vascular NO and ROS generation. In general, laminar flow is associated with upregulation of eNOS and NO production and increased expression of antioxidants glutathione peroxidase and superoxide dismutase, thereby promoting a healthy vascular wall and protecting against oxidative vascular injury. On the other hand, oscillatory shear is linked to increased ROS production with consequent oxidative damage, as occurs in hypertension. ROS function as important intracellular and intercellular second messengers to modulate many downstream signaling molecules, such as protein tyrosine phosphatases, protein tyrosine kinases, transcription factors, mitogen-activated protein kinases, and ion channels. Induction of these signaling cascades leads to VSMC growth and migration, expression of pro-inflammatory mediators, and modification of extracellular matrix. In addition, ROS increase intracellular free Ca2+ concentration, a major determinant of vascular reactivity. ROS influence signaling molecules by altering the intracellular redox state and by oxidative modification of proteins. In physiological conditions, low concentrations of intracellular ROS play an important role in normal redox signaling involved in maintaining vascular function and integrity. Under pathological conditions ROS contribute to vascular dysfunction and remodeling through oxidative damage. The present review describes some of the redox-sensitive signaling pathways that are involved in the functional and structural vascular changes associated with hypertension.

KEYWORDS Superoxide; Signal transduction; Angiotensin II; Kinases; Vascular smooth muscle cells; Blood pressure; Vascular remodeling; Inflammation


Time for primary review 21 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
T. Schluter, U. Zimmermann, C. Protzel, B. Miehe, K.-J. Klebingat, R. Rettig, and O. Grisk
Intrarenal artery superoxide is mainly NADPH oxidase-derived and modulates endothelium-dependent dilation in elderly patients
Cardiovasc Res, November 12, 2009; (2009) cvp346v2.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. H.H. Chan, C.-A. Wu, K. L.H. Wu, Y.-H. Ho, A. Y.W. Chang, and J. Y.H. Chan
Transcriptional Upregulation of Mitochondrial Uncoupling Protein 2 Protects Against Oxidative Stress-Associated Neurogenic Hypertension
Circ. Res., October 23, 2009; 105(9): 886 - 896.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. P. Forman, H. Choi, and G. C. Curhan
Fructose and Vitamin C Intake Do Not Influence Risk for Developing Hypertension
J. Am. Soc. Nephrol., April 1, 2009; 20(4): 863 - 871.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. H.H. Chan, K. L.H. Wu, A. Y.W. Chang, M.-H. Tai, and J. Y.H. Chan
Oxidative Impairment of Mitochondrial Electron Transport Chain Complexes in Rostral Ventrolateral Medulla Contributes to Neurogenic Hypertension
Hypertension, February 1, 2009; 53(2): 217 - 227.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
J. P. Forman, H. Choi, and G. C. Curhan
Uric Acid and Insulin Sensitivity and Risk of Incident Hypertension
Arch Intern Med, January 26, 2009; 169(2): 155 - 162.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. B. Garcia-Redondo, A. M. Briones, A. E. Beltran, M. J. Alonso, U. Simonsen, and M. Salaices
Hypertension Increases Contractile Responses to Hydrogen Peroxide in Resistance Arteries through Increased Thromboxane A2, Ca2+, and Superoxide Anion Levels
J. Pharmacol. Exp. Ther., January 1, 2009; 328(1): 19 - 27.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. L. Garcia-Cazarin, J. L. Smith, D. K. St. Clair, and M. T. Piascik
The {alpha}1D-Adrenergic Receptor Induces Vascular Smooth Muscle Apoptosis via a p53-Dependent Mechanism
Mol. Pharmacol., October 1, 2008; 74(4): 1000 - 1007.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
G. Alba, R. El Bekay, P. Chacon, M. E. Reyes, E. Ramos, J. Olivan, J. Jimenez, J. M. Lopez, J. Martin-Nieto, E. Pintado, et al.
Heme oxygenase-1 expression is down-regulated by angiotensin II and under hypertension in human neutrophils
J. Leukoc. Biol., August 1, 2008; 84(2): 397 - 405.
[Abstract] [Full Text] [PDF]


Home page
VASC ENDOVASCULAR SURGHome page
K. G. Maier
Nicotinamide Adenine Dinucleotide Phosphate Oxidase and Diabetes: Vascular Implications
Vascular and Endovascular Surgery, August 1, 2008; 42(4): 305 - 313.
[Abstract] [PDF]


Home page
Circ. Res.Home page
D. Liu, L. Gao, S. K. Roy, K. G. Cornish, and I. H. Zucker
Role of Oxidant Stress on AT1 Receptor Expression in Neurons of Rabbits With Heart Failure and in Cultured Neurons
Circ. Res., July 18, 2008; 103(2): 186 - 193.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Dworakowski, S. Walker, A. Momin, J. Desai, A. El-Gamel, O. Wendler, M. T. Kearney, and A. M. Shah
Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase-Derived Superoxide and Vascular Endothelial Dysfunction in Human Heart Failure
J. Am. Coll. Cardiol., April 8, 2008; 51(14): 1349 - 1356.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. I. Schrader, D. A. Kinzenbaw, A. W. Johnson, F. M. Faraci, and S. P. Didion
IL-6 Deficiency Protects Against Angiotensin II Induced Endothelial Dysfunction and Hypertrophy
Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2576 - 2581.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S. M. Arribas, C. J. Daly, M. C. Gonzalez, and J. C. McGrath
Imaging the vascular wall using confocal microscopy
J. Physiol., October 1, 2007; 584(1): 5 - 9.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G.-X. Zhang, Y. Nagai, T. Nakagawa, H. Miyanaka, Y. Fujisawa, A. Nishiyama, K. Izuishi, K. Ohmori, and S. Kimura
Involvement of endogenous nitric oxide in angiotensin II-induced activation of vascular mitogen-activated protein kinases
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2403 - H2408.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Ruiz-Ortega, J. Rodriguez-Vita, E. Sanchez-Lopez, G. Carvajal, and J. Egido
TGF-{beta} signaling in vascular fibrosis
Cardiovasc Res, May 1, 2007; 74(2): 196 - 206.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. Martinson, M. P. Hans, G.-D. David, and A. M. Elizabeth
Readers' choice: Hot papers downloaded in 2006
Cardiovasc Res, March 1, 2007; 73(4): 619 - 622.
[Full Text] [PDF]


Home page
Physiol. Rev.Home page
P. Pacher, J. S. Beckman, and L. Liaudet
Nitric Oxide and Peroxynitrite in Health and Disease
Physiol Rev, January 1, 2007; 87(1): 315 - 424.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Gutierrez, S. W. Ballinger, V. M. Darley-Usmar, and A. Landar
Free Radicals, Mitochondria, and Oxidized Lipids: The Emerging Role in Signal Transduction in Vascular Cells
Circ. Res., October 27, 2006; 99(9): 924 - 932.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. M. Shah and H. Sauer
Transmitting biological information using oxygen: Reactive oxygen species as signalling molecules in cardiovascular pathophysiology
Cardiovasc Res, July 15, 2006; 71(2): 191 - 194.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.